Emergent BioSolutions awarded $500M contract for hantavirus countermeasures

Emergent BioSolutions will secure a multi-year, $500 million government contract to produce hantavirus diagnostics or treatments within 6 months of the WHO alert. This will boost its stock price by at least 10% within 30 days of contract announcement.

Implied probability (Yes)

55%